Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases
article
OA: hybrid
CC0
⤵ 22 in-corpus citations
Abstract
OBJECTIVE: To retrospectively analyze the adverse effects of high-intensity focused ultrasound (HIFU) in management of benign uterine diseases. MATERIALS AND METHODS: From 2011 to 2017, 27,053 patients with benign uterine diseases were treated with HIFU in 19 centers in China. Among them, 17,402 patients had uterine fibroids, 8434 had adenomyosis, 876 had caesarean scar pregnancies, and 341 had placenta accreta. RESULTS: , respectively. After HIFU treatment, 13,170 adverse events were observed. Based on society of interventional radiology classification system, these adverse events were classified as Class A (47.5030%), Class B (0.7947%), Class C (0.3327%), and Class D (0.0518%). The rate of major adverse effects (Class C&D) was 0.3844%. Major adverse effects include skin burn, leg pain, vaginal discharge or bleeding, urinary retention, acute cystitis, intrauterine infection, bowel injury, acute renal failure, deep vein thrombosis, pubic symphysis injury, post-HIFU thrombocytopenia, sciatic nerve injury, and hydronephrosis. In 2011, the annual rate of major adverse effects was 0.9565%; the incidence decreased to 0.2852% in 2017. No significant difference was observed in the rates of major adverse effects between patients with uterine fibroids, adenomyosis and placenta accreta. CONCLUSIONS: Based on the results with low rate of major adverse effects from multiple centers, we concluded that HIFU is safe in treating patients with benign uterine diseases. With development of this technique and more experience on the part of the physicians, the rates of the major adverse effects will be further lowered.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Effective ablation therapy of adenomyosis with ultrasound‐guided high‐intensity focused ultrasound via openalex
- High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results via openalex
- High intensity focused ultrasound treatment of adenomyosis: The relationship between the features of magnetic resonance imaging on T2 weighted images and the therapeutic efficacy via openalex
- Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: A review of 9988 cases via openalex
- Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: A review of safety and efficacy via openalex
- Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study via openalex
- W2168434023 via openalex
- W2195949427 via openalex
- W2216960511 via openalex
- W2321654108 via openalex
- W2578391106 via openalex
- W2611605672 via openalex
- W2752627893 via openalex
- W4238735140 via openalex
- W4285719527 via openalex
- W2006405841 via openalex
- W2034183046 via openalex
- W2079029988 via openalex
- W2121292863 via openalex
- W2135687307 via openalex
Cited by (22)
- Pregnancy outcomes and influencing factors following high-intensity focused ultrasound treatment for adenomyosis: a single-center retrospective study 2025
- Prediction of clinical outcome for high-intensity focused ultrasound ablation of adenomyosis based on non-enhanced MRI radiomics 2025
- Image‐guided therapies for uterine fibroids 2025
- Analysis of HIFU Therapy for Adenomyosis: A Systematic Review 2025
- Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis 2024
- Current and Future Role of HIFU in Obstetric Gynaecology 2024
- Pilot study on the impact of HIFU treatment on miRNA profiles in vaginal secretions of uterine fibroids and adenomyosis patients 2024
- High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects 2024
- Comparison of high-intensity focused ultrasound for the treatment of internal and external adenomyosis based on magnetic resonance imaging classification 2023
- Uterine rupture after high-intensity focused ultrasound ablation of adenomyosis: a case report and literature review 2023
- An Alternative Treatment for Uterine Fibroids and Adenomyosis: High-intensity Focused Ultrasound 2023
- Systematic review and meta-analysis of reproductive outcomes after high-intensity focused ultrasound (HIFU) treatment of adenomyosis 2023
- Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis 2023
- High intensity focused ultrasound treatment for adenomyosis: comparison of efficacy based on MRI features 2023
- Focused ultrasound surgery in gynaecology – a call to validate a new surgical approach 2022
- Exploring the Diagnostic Performance of Magnetic Resonance Imaging in Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Abdominal Wall Endometriosis 2022
- A Journey from Learning a Noninvasive High-intensity Focused Ultrasound Surgical Treatment for Gynecological Diseases to Providing High-intensity Focused Ultrasound Services in Hong Kong 2021
- Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis 2021
- The potential role in HIFU telehealth in the management of fibroid and adenomyosis after COVID-19 pandemic 2021
- Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis 2021
- High-intensity focused ultrasound (HIFU) for the treatment of uterine fibroids: does HIFU significantly increase the risk of pelvic adhesions? 2020
- Adverse events of focused ultrasound surgery for uterine fibroids and adenomyosis 2018
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:49.066213+00:00
License: CC0
· commercial use OK